Sarepta Therapeutics Inc (NASDAQ:SRPT)

78.55
Delayed Data
As of Apr 19
 -2.41 / -2.98%
Today’s Change
28.82
Today|||52-Week Range
84.37
+41.18%
Year-to-Date
Pfizer Starts Phase Ib for Duchenne Muscular Dystrophy Drug
Apr 13 / Zacks.com - Paid Partner Content